RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2007;18:551-554
doi:10.1258/095646207781439784
© 2007 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moss, S
Right arrow Articles by Mallinson, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

The contribution of APTIMA Combo 2 assay to the diagnosis of gonorrhoea in genitourinary medicine setting

S Moss and H Mallinson

Genito-Urinary Medicine, St Helens Hospital, Marshalls Cross Road, St Helens, Merseyside,UK; Clinical Microbiology and Health Protection Agency Collaborating Laboratory, University Hospital Aintree, Aintree, UK

For 929 female and 821 male patients attending a genitourinary clinic, samples intended for chlamydia diagnosis were dual tested by nucleic acid amplification for both chlamydia and Neisseria gonorrhoeae (NG). The assay used, Gen-probe APTIMA Combo 2 (AC2) detected all cases of NG found by conventional microscopy and culture. AC2 identified additional patients who had partners with NG, but were themselves negative by microscopy and culture. Few, if any, false-positive AC2 results were found. Use of AC2 increased the number of patients treated for NG. It can reduce the number of specimens required and may limit the need for multiple site testing.

Key Words: SEXUAL HEALTH TARGETS • APTIMA COMBO 2 • NATIONAL CLINICAL OPERATING PROCEDURE • GONORRHOEA FALSE-POSITIVES • POSITIVE PREDICTIVE VALUE • NEAR PATIENT TESTING FOR GONORRHOEA MORE ACCEPTABLE • NUCLEIC ACID AMPLIFICATION TESTS


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int J STD AIDSHome page
B. Serisha, M. Sillis, and J. Evans
Confirmation of reactive gonorrhoea Gen Probe APTIMA Combo 2 assay using the alternative sequence mono-specific APTIMA gonococcus assay
Int J STD AIDS, January 1, 2008; 19(1): 69 - 69.
[Full Text] [PDF]



Walking London's Medical History